Drug intelligence / Profile preview

Zfra1-31

Development stage
Preclinical
Lead developer
National Cheng Kung University
Modality
Peptides
Administration
Intravenous
01

Overview

Zfra1-31 is a synthetic 31-amino-acid peptide corresponding to the full-length Zinc finger-like protein for regulating apoptosis (Zfra). It functions as a regulator of apoptosis by participating in the mitochondrial pathway and modulating the activity of tumor suppressors such as WWOX and p53. Zfra1-31 induces a novel form of protein degradation termed "zfration," which occurs independently of the ubiquitin-proteasome system. It has been shown to suppress the phosphorylation of WWOX at Ser14, thereby inhibiting the docking and growth of metastatic melanoma cells in the lung and liver. Additionally, it interacts with membrane hyaluronidase Hyal-2 and stimulates specific memory lymphocytes. Preclinical studies in mouse models have demonstrated its potential in preventing skin cancers, including melanoma and basal cell carcinoma.

Other names
Zinc finger-like protein for regulating apoptosis (1-31)full-length Zfra
02

Targets

pS14-WWOX (WW domain-containing oxidoreductase (WWOX) phosphorylated at Serine 14)TP53 (Cellular Tumor Antigen p53 R175H)Hyaluronidase 2-expressing splenic Z cell

Beyond the preview

Go deeper on Zfra1-31.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zfra1-31.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call